17 results
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... 5 or elevated Cr ... - pulmonary opacities ... initiation • Differential ... organ dysfuxtion, ICU
Differential diagnosis
The table summarizes the most common diseases, that present with consolidation.
Chronic diseases are indicated in
The table summarizes ... respond to the treatment ... Diagnosis #Radiology #Pulmonary ... #CXR #Consolidation ... #Table #RadiologyAssistant
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Clinical ... Blood cultures • CXR ... early disease) • CXR ... Lung #Abscess #pulmonary ... #differential #
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... fluid balance, and CXR ... with pulmonary ... diagnosis #comparison #table
Figure 3 HRCT-LUS correlation in normal lung, pulmonary congestion, rheumatoid lung disease, idiopathic pulmonary fibrosis.
Notes: (A)
in normal lung, pulmonary ... disease, idiopathic pulmonary ... B-lines in one IC ... #Clinical #Diagnosis ... #Correlation #Table
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... & Dry) is the treatment ... #diagnosis #differential ... #table #foamed ... #criticalcare #icu
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Therapy (LAMA/LABA/ICS ... Dosing: 250 mcg tablet ... recommendations for the treatment ... low, adding an ICS ... won’t have any clinical
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Clinical Picture ... life-threatening Differential ... Diagnosis - Clinical ... Clinical DX: - ... Bedside: ice pack
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... staining, NAA (PCR ... and Culture • CXR ... Tuberculosis Treatment ... disease • Check CXR
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... staining, NAA (PCR ... and Culture • CXR ... Tuberculosis Treatment ... disease • Check CXR